This topic contains a solution. Click here to go to the answer

Author Question: Selective estrogen-receptor modulators such as tamoxifen and aromatase inhibitors reduce the ... (Read 56 times)

Jramos095

  • Hero Member
  • *****
  • Posts: 528
Selective estrogen-receptor modulators such as tamoxifen and aromatase inhibitors reduce the proliferation of certain types of breast cancer cells by
 
  A) blocking their uptake of estrogen.
  B) degrading the blood vessels that supply them with estrogen.
  C) increasing ovarian estrogen production.
  D) increasing ovarian production of progesterone.

Question 2

The 1918 flu pandemic
 
  A) struck mainly Americans and Canadians.
  B) struck nearly 10 percent of the world's population.
  C) killed more than 50 million people.
  D) was also known as the Hong Kong flu.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Carliemb17

  • Sr. Member
  • ****
  • Posts: 325
Answer to Question 1

A

Answer to Question 2

C




Jramos095

  • Member
  • Posts: 528
Reply 2 on: Jul 12, 2018
YES! Correct, THANKS for helping me on my review


carojassy25

  • Member
  • Posts: 299
Reply 3 on: Yesterday
Excellent

 

Did you know?

The tallest man ever known was Robert Wadlow, an American, who reached the height of 8 feet 11 inches. He died at age 26 years from an infection caused by the immense weight of his body (491 pounds) and the stress on his leg bones and muscles.

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

Many medications that are used to treat infertility are injected subcutaneously. This is easy to do using the anterior abdomen as the site of injection but avoiding the area directly around the belly button.

Did you know?

Egg cells are about the size of a grain of sand. They are formed inside of a female's ovaries before she is even born.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

For a complete list of videos, visit our video library